Tenon Medical Inc (NAS:TNON)

Q3 2024 Tenon Medical Inc Earnings Call Transcript

Nov 13, 2024 / 09:30 PM GMT

Release Date Price: $3.3 (-4.07%)

Transcript 10-Q

Key Points

Positve

Tenon Medical Inc (TNON) reported an 18% year-over-year increase in revenue for the first nine months of 2024, driven by a 5% rise in surgical procedures using the catamaran system.
Gross margin improved significantly by 2,200 basis points to 54% for the first nine months of 2024 compared to the same period last year.
The company strengthened its balance sheet with an investment from a healthcare-focused institutional investor, resulting in net proceeds of approximately $9.6 million.
Tenon Medical Inc (TNON) has made considerable commercialization and technical advances, including the development of a second-generation, smaller version of the catamaran implant.
The company received three new patents related to its enhanced catamaran prosthesis, strengthening its competitive position in the industry.

Negative

Revenue declined by 6% in the third quarter of 2024 compared to the same quarter in 2023, primarily due to unexpected reimbursement preauthorization headwinds.
Gross profit margin decreased to 47% in the third quarter of 2024 from 57% in the same quarter of 2023.
Operating expenses remain high, totaling $3.6 million for the third quarter of 2024, although this is a slight decrease from the previous year.
The company reported a net loss of $3.2 million for the third quarter of 2024, indicating ongoing financial challenges.
Tenon Medical Inc (TNON) anticipates incurring additional losses in the future as it continues to invest in growth initiatives.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TNON.OQ - Tenon Medical Inc
Q3 2024 Tenon Medical Inc Earnings Call
Nov 13, 2024 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, to assist the operator. Today's conference is scheduled to begin momentarily until that time your alliance will remain on music. Hold. Thank you for your patience.

Greetings and welcome to the tenant medical third quarter, 2024 financial results and corporate update conference call. As a reminder, this call is being recorded. Your host today are Steven Foster, President and Chief Executive Officer and Kevin Williamson, Chief Financial Officer, Mr Foster and Mr Williamson will present results of operations for the third quarter ended September 32,024 and provide a corporate update.

A press release detailing these results was released today and is available on the investor relations section of our

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.